Se帽ales de una “vacuna sorpresa en octubre” alarma a cient铆ficos de carrera
El presidente Donald Trump, que parece decidido a anunciar una vacuna para COVID-19 antes de las elecciones, podr铆a autorizarla legalmente a pesar de las objeciones.
Signs of an 鈥極ctober Vaccine Surprise鈥 Alarm Career Scientists
President Donald Trump has the legal power to authorize a COVID vaccine over the objections of the Food and Drug Administration and vaccine manufacturers. Such a move could further erode public trust in a vaccine and foist an unsafe shot on Americans.
Dozens of U.S. Hospitals Poised to Defy FDA鈥檚 Directive on COVID Plasma
The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they鈥檒l opt instead to use the scarce resource to complete a clinical trial.
With COVID Vaccine Trial, Rural Oregon Clinic Steps Onto World Stage
A small allergy clinic in Medford, Oregon, might seem an unlikely place to recruit hundreds of volunteers to test the Moderna vaccine against COVID-19. But its steward has a record of leading hundreds of clinical trials.
鈥淟ost on the Frontline鈥 is an ongoing project by Kaiser Health News and The Guardian that aims to document the lives of health care workers in the U.S. who died from COVID 19, and to investigate why so many are victims of the disease.
Test Sites Quickly Attract Thousands for COVID-19 Vaccine Study
People have flooded U.S. testing sites with requests to participate in the pivotal, late-stage clinical trials of the first two COVID-19 vaccine candidates.
El color de COVID: 驴los ensayos de vacunas reflejan la diversidad de Estados Unidos?
Las personas de raza negra y las latinas (que pueden ser de cualquier raza) tienen tres veces m谩s probabilidades de infectarse con el coronavirus que causa COVID-19 que las personas blancas no hispanas
The Color of COVID: Will Vaccine Trials Reflect America鈥檚 Diversity?
Although racial minorities, older people and those with underlying medical conditions are most at risk from COVID-19, they鈥檝e historically been the least likely to be included in clinical trials for treatments for serious diseases. Will that change with COVID-19?
Bingeing on Doom: Expert on the 鈥楤lack Death鈥 Attracts Cult Following
A 2016 series on the 14th-century plague became must-see TV during spring鈥檚 COVID-19 outbreak 鈥 and flooded Purdue medievalist Dorsey Armstrong with questions about parallels between that pandemic and the current crisis.
鈥業 Couldn鈥檛 Let Her Be Alone鈥: A Peaceful Death Amid the COVID Scourge
For three years, staffers at UCLA Health have been quietly fulfilling final wishes for dying patients in the intensive care unit. Amid the isolating forces of the pandemic, their work has become all the more meaningful.
Hype Collides With Science As FDA Tries To Rein In 鈥榃ild West鈥 of COVID Blood Tests
Amid questions about the accuracy of the COVID-19 antibody tests flooding the market 鈥 and the usefulness of the results they provide 鈥 the FDA has belatedly stepped in to try to rein in the chaos.
鈥榃e Miss Them All So Much鈥: Grandparents Ache As The COVID Exile Grinds On
The pandemic has forced millions of families to weigh the risks of vulnerable grandparents getting too close to their beloved grandchildren 鈥 against the heartache of staying away.
COVID Survivors鈥 Blood Plasma Is A Sought-After New Commodity
A possibility that the blood of people who had COVID could save others has set off a mad scramble for donors 鈥 with top-dollar offers and a plan that relies on the blood of 10,000 Orthodox Jewish women.
Consumer Beware: Coronavirus Antibody Tests Are Still A Work In Progress
Public officials are putting high hopes on new blood tests as a means of determining who has developed antibodies to COVID-19, and with those antibodies, presumed immunity. But experts caution the tests are largely unreliable and the science is still catching up.
Alerta al consumidor: pruebas de anticuerpos para COVID-19 todav铆a se est谩n desarrollando
Funcionarios de la Organizaci贸n Mundial de la Salud se manifestaron en contra de los planes de algunos pa铆ses de tener “pasaportes de inmunidad”, que habilitar铆an a salir y trabajar.
Nacer en medio de la pandemia: COVID-19 complica los partos y la relaci贸n mam谩-beb茅
En todo los Estados Unidos, COVID-19 est谩 alterando radicalmente la atenci贸n m茅dica, no solo para los adultos mayores vulnerables sino tambi茅n para las embarazadas y sus reci茅n nacidos.
Born Into A Pandemic: Virus Complicates Births For Moms And Babies
COVID-19 is changing medical care, not only for vulnerable elders but also for pregnant women and their babies entering the world.
A Desperate Scramble As COVID-19 Families Vie For Access To Plasma Therapy
As efforts ramp up to collect blood plasma from the first survivors of COVID-19, families of critically ill patients are jockeying to obtain the still-unproven antibody treatment.
鈥榊ou Pray That You Got The Drug.鈥 Ailing Couple Gambles On Trial For COVID-19 Cure
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
Blood Centers Will Collect Plasma From COVID-19 Survivors In Bid For Treatment
New guidelines issued Tuesday could speed a century-old therapy to those critically ill with the pandemic virus.
